Allergan plc:企業のM&A・事業提携・投資動向

◆英語タイトル:Allergan plc - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report
◆商品コード:DATA904C2035
◆発行会社(調査会社):MarketLine
◆発行日:2018年7月
◆ページ数:122
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アイルランド
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD350 ⇒換算¥51,800見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD700 ⇒換算¥103,600見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD1,050 ⇒換算¥155,400見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はMarketLine社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
MarketLine社の概要はこちらでご確認いただけます。



【レポートの概要】

Allergan plc – Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report
Summary

Marketline’s Allergan plc Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), divestments, capital raisings, venture capital investments, ownership and partnership transactions undertaken by Allergan plc since January2007.

Synopsis

Marketline’s Company Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage.

Key Highlights

This report includes Allergan plc’s contact information and business summary, tables, graphs, a list of partners and targets, a breakdown of financial and legal advisors, deal types, top deals by deal value, detailed deal reports, and descriptions and contact details of the partner, target, investor, and vendor firms, where disclosed.

The profile also includes detailed deal reports for all M&A, private equity, public offering, venture financing, partnership and divestment transactions undertaken by Allergan plc. These deal reports contain information about target company financials, sources of financing, method of payment, deal values, and advisors for various parties, where disclosed.

Scope

- Provides intelligence on Allergan plc’s M&A, strategic partnerships and alliances, capital raising and private equity transactions.
- Detailed reports of various financial transactions undertaken by Allergan plc and its subsidiaries since 2007.
- Information about key financial and legal advisors for Allergan plc’s financial deals transactions.
- Financial deals tables and charts covering deal value and volumes trend, deal types and geography-based deal activity.

Reasons to buy

- Access comprehensive financial deals data along with charts and graph covering M&A, private equity, and partnerships and alliances.
- Form an independent opinion about Allergan plc’s growth strategies through the organic and inorganic activities undertaken since 2007.
- Track your competitors’ business structure and growth strategies.

【レポートの目次】

Table of Contents
COMPANY OVERVIEW AND KEY FACTS 2
TABLE OF CONTENTS 5
LIST OF TABLES 7
LIST OF FIGURES 7
TARGETS AND PARTNERS 8
MERGERS & ACQUISITIONS 9
Mergers and Acquisitions – Overview 9
Mergers and Acquisitions – Deal reports 10
PARTNERSHIP 18
Partnership – Overview 18
Partnership – Deal reports 19
CAPITAL RAISING 67
Capital Raising – Overview 67
Capital Raising – Deal reports 68
DIVESTMENTS 78
Divestments – Overview 78
Divestments – Deal reports 79
PRIVATE EQUITY & OWNERSHIP 110
Private Equity and Ownership – Overview 110
Private Equity and Ownership – Deal reports 111
APPENDIX 112
Contact Us 112
About MarketLine Financial Deals Database 112
Deal Definition and Methodology 114
About MarketLine 121

List of Tables
Table 1: Allergan Plc M&A volume and value trend (2014-YTD2018)
Table 2: Allergan Plc M&A activity by geography (2014-YTD2018)
Table 3: Allergan Plc partnership volume and value trend (2014-YTD2018)
Table 4: Allergan Plc partnership trend by key deal type (2014-YTD2018)
Table 5: Allergan Plc capital raising volume and value trend (2014-YTD2018)
Table 6: Allergan Plc capital raising by deal type (2014-YTD2018)
Table 7: Allergan Plc divestments volume and value trend (2014-YTD2018)
Table 8: Allergan Plc divestments activity by geography (2014-YTD2018)
Table 9: Allergan Plc private equity and ownership volume and value trend (2014-YTD2018)
Table 10: Allergan Plc private equity and ownership activity by deal type (2014-YTD2018)

List of Figures
Figure 1: Allergan Plc M&A volume and value trend (2014-YTD2018)
Figure 2: Allergan Plc M&A activity by geography (2014-YTD2018)
Figure 3: Allergan Plc partnership volume and value trend (2014-YTD2018)
Figure 4: Allergan Plc partnership trend by key deal type (2014-YTD2018)
Figure 5: Allergan Plc capital raising volume and value trend (2014-YTD2018)
Figure 6: Allergan Plc capital raising by deal type (2014-YTD2018)
Figure 7: Allergan Plc divestments volume and value trend (2014-YTD2018)
Figure 8: Allergan Plc divestments by geography (2014-YTD2018)
Figure 9: Allergan Plc private equity and ownership volume and value trend (2014-YTD2018)
Figure 10: Allergan Plc private equity and ownership by deal type (2014-YTD2018)

★海外企業調査レポート[Allergan plc:企業のM&A・事業提携・投資動向]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Luye Pharma Group Co Ltd (2186):製薬・医療:M&Aディール及び事業提携情報
    Summary Luye Pharma Group Co Ltd (Luye Pharma) is a pharmaceutical company that develops, produces and markets pharmaceutical products in the therapeutic areas of oncology, cardiovascular, metabolism and central nervous system. The company’s products include sodium aescinate for injection, xuezhikan …
  • City Holding Co (CHCO):企業の財務・戦略的SWOT分析
    City Holding Co (CHCO) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses an …
  • TXU Energy Retail Company LLC:企業の戦略的SWOT分析
    TXU Energy Retail Company LLC - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major produ …
  • Calix, Inc. (CALX):企業の財務・戦略的SWOT分析
    Calix, Inc. (CALX) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and th …
  • Tom N Toms Holdings Co., Ltd.:企業の戦略・SWOT・財務分析
    Tom N Toms Holdings Co., Ltd. - Strategy, SWOT and Corporate Finance Report Summary Tom N Toms Holdings Co., Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and …
  • United Spirits Ltd:企業のM&A・事業提携・投資動向
    United Spirits Ltd - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's United Spirits Ltd Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), d …
  • University of Texas Southwestern Medical Center-医療機器分野:企業M&A・提携分析
    Summary University of Texas Southwestern Medical Center (UTSMC), a subsidiary of University of Texas System is an educational center that offers medical research and education programs. The center offers degree programs, which include master's degree in business administration, public health, medica …
  • Allergy Therapeutics Plc (AGY)-製薬・医療分野:企業M&A・提携分析
    Summary Allergy Therapeutics Plc (Allergy Therapeutics) is a specialty pharmaceutical company that develops therapies for allergy treatment and allergy prevention. The company offers a wide range of aluminium-free allergy vaccines and diagnostics. It uses Micro Crystalline Tyrosine (MCT) as an alter …
  • Premaitha Health Plc (NIPT):企業の財務・戦略的SWOT分析
    Premaitha Health Plc (NIPT) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakness …
  • Emerson Electric Co (EMR):企業の財務・戦略的SWOT分析
    Emerson Electric Co (EMR) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses …
  • Pacgen Life Science Corp (PBS):企業の財務・戦略的SWOT分析
    Summary Pacgen Life Science Corp (Pacgen), formerly Pacgen Biopharmaceuticals Corp, is a life science technology company that develops and commercializes biomedical products and services. The company offers development of novel therapeutic drug candidates. It provides product such as include amino-a …
  • Acadia Pharmaceuticals Inc (ACAD)-製薬・医療分野:企業M&A・提携分析
    Summary Acadia Pharmaceuticals Inc (Acadia) discovers, develops and commercializes small molecule drugs for the treatment of central nervous system disorders. The company’s lead product Nuplazid (pimavanserin) is an FDA approved drug for the treatment of Parkinson’s disease psychosis. Acadia also de …
  • ManpowerGroup Inc (MAN):企業の財務・戦略的SWOT分析
    ManpowerGroup Inc (MAN) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses a …
  • Syntimmune Inc:製薬・医療:M&Aディール及び事業提携情報
    Summary Syntimmune Inc (Syntimmune) is a clinical-stage biotechnology company that focuses to develop Fc receptor (FcRn) based antibody therapeutics for the treatment of autoimmune diseases. Its lead pipeline products includes SYNT001, an investigational humanized IgG4 monoclonal antibody that inhib …
  • Heron Therapeutics Inc (HRTX):企業の財務・戦略的SWOT分析
    Heron Therapeutics Inc (HRTX) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakne …
  • Union Jack Oil plc (UJO):企業の財務・戦略的SWOT分析
    Summary Union Jack Oil Plc (Union Jack Oil), formerly Union Jack Oil Ltd is an onshore oil and gas company that offers exploration and development of hydrocarbon projects. The company develops its portfolio of oil and gas assets by acquiring interests in drill ready prospects. It holds license inter …
  • Sun BioPharma Inc (SNBP):企業の財務・戦略的SWOT分析
    Summary Sun BioPharma Inc (Sun BioPharma), formerly Cimarron Medical Inc is a biopharmaceutical company that develops disruptive therapeutics for treatment of pancreatic cancer and pancreatitis. The company’s pipeline products include SBP-101, SBP-102 and SBP-103. Its SBP-101 produces superior anti- …
  • Cafes Novell SA:企業の戦略・SWOT・財務分析
    Cafes Novell SA - Strategy, SWOT and Corporate Finance Report Summary Cafes Novell SA - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corpo …
  • VEON Ltd:企業の戦略・SWOT・財務分析
    VEON Ltd - Strategy, SWOT and Corporate Finance Report Summary VEON Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, …
  • Ion Beam Applications SA (IBAB):医療機器:M&Aディール及び事業提携情報
    Summary Ion Beam Applications SA (IBA) develops solutions for the diagnosis and treatment of cancer. It offers monitoring equipment and software that enables hospitals to perform calibration procedures during radiation therapy and radiology. The company focuses its activities on proton therapy solut …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆